There are 2867 resources available
State-of-the art first-line therapy for mCRC
Presenter: Chiara Cremolini
Session: Personalizing treatment for mCRC in 2022
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Ines Vaz Luis
Session: Leveraging biology and technology to improve symptoms and quality of life of cancer survivors
Resources:
Slides
Webcast
Introduction
Presenter: All Speakers
Session: ESMO meets pharma: Next frontiers in drug discoveries
Resources:
Webcast
LBA41 - Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
Presenter: Paolo Ascierto
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Introduction and scientific background
Presenter: Boris Hadaschik
Session: Prostate-specific membrane antigen (PSMA) biology, diagnostics and treatment
Resources:
Slides
Webcast
Follicular lymphoma
Presenter: Catherine Thieblemont
Session: Early relapses in lymphoma: How to treat?
Resources:
Slides
Webcast
1452MO - Longitudinal analysis reveals gut microbiota shift during standard therapies in metastatic renal cell carcinoma (mRCC)
Presenter: Carolina Alves Costa Silva
Session: Mini Oral session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
1647MO - BRAF mutated anaplastic thyroid carcinoma: Clinical characteristics and outcome under BRAF inhibitors and chemotherapy in real-life practice, a multicentric retrospective study of the French ENDOCAN TUTHYREF network
Presenter: Christelle de la Fouchardiere
Session: Mini Oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
136MO - Differential benefit of low-dose cyclophosphamide and methotrexate maintenance chemotherapy among TNBC subtypes in the context of the IBCSG 22-00 study
Presenter: Andrea Joaquin Garcia
Session: Mini Oral session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Polygenic risk scores for cancer risk prediction: How far are we from wide clinical use?
Presenter: Monserrat Garcia-Closas
Session: How advances in biology and technology are transforming the field of cancer prevention & early detection
Resources:
Slides
Webcast